Ignite Creation Date:
2025-12-24 @ 3:32 PM
Ignite Modification Date:
2026-02-04 @ 11:04 PM
Study NCT ID:
NCT05810792
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-11-22
First Post:
2023-03-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Histamine Dihydrochloride and Interleukin-2 in Primary Resectable Pancreatic Cancer
Sponsor:
Sahlgrenska University Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
PANCEP-1, April 1 2020
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None